Biotechnology, Research, and Healthcare by ACADIA Pharmaceuticals
Acadia Pharmaceuticals stock gains 6% as price reclaims $25.69 MA-20 support
Acadia Pharmaceuticals released its second-quarter 2026 earnings results in a post shared by the company. At the same time, Acadia Pharmaceuticals stock is up 6% on the day at $27.15.The company ...
FDA Fast Track designation for Alzheimer therapy confirmed as Acadia Pharmaceuticals stock faces selling pressure
Acadia Pharmaceuticals announced that the U.S. Food and Drug Administration has granted Fast Track designation to its investigational therapy for the treatment of Alzheimer’s Disease ...
FDA fast track designation for Alzheimer psychosis therapy announced while Acadia Pharmaceuticals stock declines
Acadia Pharmaceuticals said the U.S. Food and Drug Administration has granted Fast Track designation to its investigational therapy for Alzheimer's Disease psychosis.The company announced the news ...
Acadia Pharmaceuticals stock surges 6.75% as CHMP backs Rett syndrome drug, Acadia Pharmaceuticals announces
Acadia Pharmaceuticals announced that the Committee for Medicinal Products for Human Use has adopted a positive opinion recommending marketing authorization for its treatment for the ...
Acadia Pharmaceuticals stock rallies after EU panel supports Rett syndrome medicine approval
Acadia Pharmaceuticals announced that the Committee for Medicinal Products for Human Use has adopted a positive opinion recommending marketing authorization for its treatment for neurobehavioral ...
Acadia Pharmaceuticals stock climbs 3.36% as Acadia Pharmaceuticals gears up for RettSyndrome meeting
Acadia Pharmaceuticals will present its latest data in Rett Syndrome at the upcoming RettSyndrome Scientific Meeting.Acadia Pharmaceuticals stated it will join clinicians, researchers, and Rett ...
Acadia Pharmaceuticals stock holds near $21.56 as company supports Alzheimer awareness month
Acadia Pharmaceuticals announced June as Alzheimer’s and Brain Awareness Month, an initiative founded by the Alzheimer’s Association to raise awareness about Alzheimer’s disease.The company ...
Acadia Pharmaceuticals stock trades down with sideways action after recent recovery
Acadia Pharmaceuticals marked June as Alzheimer's and Brain Awareness Month, an initiative founded by the Alzheimer's Association to increase awareness of Alzheimer's disease.The company stated ...
Acadia Pharmaceuticals stock edges higher to $21.72 as AcadiaPharma promotes Parkinsons findings in D.C.
Acadia Pharmaceuticals announced it is traveling to Washington D.C. this week for the PMDAlliance #ATMRD2026 Congress.The company will share its latest findings in Parkinson's Disease psychosis ...
Acadia Pharmaceuticals stock edges higher to $21.72 as AcadiaPharma promotes Parkinsons study event
Acadia Pharmaceuticals is traveling to Washington D.C. this week for the PMD Alliance #ATMRD2026 Congress.The company will share its latest findings in Parkinson's Disease psychosis and Essential ...
